| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one |
| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody) |
| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| 11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one |
| 11-cyclopropyl-4-methyl-5H-dipyrido[2,3-b:3',2'-e][1,4]diazepin-6-one |
| 11-Cyclopropyl-4-methyl-5H-dipyrido[3,2-b |
| 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE |
| 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one |
| 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one |
| 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[2,3-B:3',2'-E][1,4]DIAZEPIN-6-ONE |
| 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one |
| 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one |
| 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one |
| 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE |
| 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B',3'-E][1,4]DIAZEPIN-6-ONE |
| 129618-40-2 |
| 1vrt |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0;{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one |
| 2-CYCLOPROPYL-7-METHYL-2,4,9,15-TETRAAZATRICYCLO[9.4.0.0(3,8)]PENTADECA-1(11),3,5,7,12,14-HEXAEN-10-ONE |
| 2-CYCLOPROPYL-7-METHYL-2,4,9,15-TETRAAZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3,5,7,12,14-HEXAEN-10-ONE |
| 2-CYCLOPROPYL-7-METHYL-2,4,9,15-TETRAAZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-10-ONE |
| 2-CYCLOPROPYL-7-METHYL-2,4,9,15-TETRAAZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3(8),4,6,11,13-HEXAEN-10-ONE |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0(3),]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one |
| 2hny |
| 5-Cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one |
| 5H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 5,11-dihydro-11-cyclopropyl-4-methyl- |
| 618N402 |
| 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- |
| 6H-DIPYRIDO[2,3-B:3',2'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- |
| 6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- |
| 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- |
| 99DK7FVK1H |
| AB0013383 |
| AB00393001_16 |
| AB00393001_17 |
| AB00393001-13 |
| AB00393001-15 |
| AB07544 |
| AB2000266 |
| AC-643 |
| AC1L1I81 |
| AJ-08226 |
| AK143126 |
| AKOS005504351 |
| ALBB-027264 |
| AN-15635 |
| BBL010768 |
| BC206673 |
| BDBM1434 |
| BI RG 587 |
| BI-RG 587 |
| BI-RG-587 |
| BI-RG-587 & CD4-IgG |
| BIDD:GT0326 |
| Bio-0789 |
| BIRG 0587 |
| BIRG 587 |
| BIRG-0587 |
| BIRG-587 |
| BIRG587 |
| C07263 |
| C15H14N4O |
| Cahill May Roberts Brand of Nevirapine |
| CAS-129618-40-2 |
| CCG-100939 |
| CHEBI:63613 |
| CHEMBL57 |
| CPD000048458 |
| CS-2252 |
| CTK8E7455 |
| D00435 |
| D0O2EM |
| DB00238 |
| DR000811 |
| DSSTox_CID_10787 |
| DSSTox_GSID_31797 |
| DSSTox_RID_78889 |
| DTXSID7031797 |
| F2173-0607 |
| FT-0607215 |
| H954 |
| HMS2051J09 |
| HMS2231O23 |
| HMS3264D21 |
| HMS3371E03 |
| HMS3393J09 |
| HMS3655I08 |
| HSDB 7164 |
| HY-10570 |
| I02-0310 |
| KB-64802 |
| KS-00000KZF |
| KS-5019 |
| LS-2289 |
| MCULE-8608154492 |
| MFCD00866928 |
| MLS000084585 |
| MLS000759409 |
| MLS001055309 |
| MLS001201730 |
| MLS001424058 |
| MLS006011423 |
| MolPort-002-507-817 |
| N0922 |
| N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin |
| NC00189 |
| NCGC00065890-02 |
| NCGC00065890-03 |
| NCGC00065890-04 |
| NCGC00065890-05 |
| NCGC00065890-07 |
| NCGC00258324-01 |
| NEV |
| NEVARAPINE |
| nevirapine |
| Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard |
| Nevirapine (JAN/USP/INN) |
| Nevirapine (Viramune) |
| Nevirapine [USAN:INN] |
| Nevirapine [USAN:USP:INN:BAN] |
| Nevirapine & CD4-IgG |
| Nevirapine & PRO 140 |
| Nevirapine anhydrous |
| Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard |
| Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Nevirapine solution, 1.0 mg/mL in methanol, certified reference material |
| Nevirapine, pharmaceutical secondary standard; traceable to USP, PhEur |
| NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE |
| NQDJXKOVJZTUJA-UHFFFAOYSA-N |
| NSC 641530 |
| NSC-641530 |
| NSC-759902 |
| NSC641530 |
| NSC759902 |
| NVP |
| Opera_ID_934 |
| Pharmakon1600-01503842 |
| PL004639 |
| PL040500 |
| PL044148 |
| Promeco Brand of Nevirapine |
| R3924 |
| RL01415 |
| RT-014690 |
| S1742 |
| SAM001246551 |
| SC-17266 |
| SCHEMBL3318 |
| SMR000048458 |
| ST24038235 |
| STK580320 |
| Tox21 110982 |
| Tox21_110982 |
| Tox21_110982_1 |
| Tox21_200770 |
| UNII-99DK7FVK1H |
| Viramune |
| Viramune (TN) |
| Viramune IR |
| Viramune, BI-RG 587, Nevirapine |
| Viramune;BI-RG 587 |
| Viramune(TM) |
| Z1695906730 |
| ZB000592 |
| ZINC4778 |
